Albers Jeffrey W.
- SEC CIK
- 0001638474
In the past year, 3 open-market sale filings worth $3.15M and no purchases.
Current role at each company
- SYRE Spyre Therapeutics, Inc.Directoras of Aug 10, 2026
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 25, 2026
- BPMC Blueprint Medicines CorpDirectoras of Jul 21, 2025
- DNTH Dianthus Therapeutics, Inc.Directoras of Jun 30, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.15M
- 3 filings
- Net
- −$3.15M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Albers Jeffrey W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYRE Spyre Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 (view filing) | Oct 25 | 3 days | Albers Jeffrey W.Director | SSale | −300 | $36.43 | −$10.9K | −0.9%34.1K after | 10b5-1 |
| Nov 8, 2024 (view filing) | Nov 6 | 2 days | Albers Jeffrey W.Director | SSale | −6.70K | $36.76 | −$246.3K | −19.7%27.4K after | 10b5-1 |
| Aug 10, 2026 (view filing)9:31 PM ET | Aug 7 | 3 days | Albers Jeffrey W.Director | SSale | −5.00K | $104.47 | −$522.4K | −100.0%0 after | 10b5-1 |
| Aug 10, 2026 (view filing)9:31 PM ET | Aug 7 | 3 days | Albers Jeffrey W.Director | SSale | −18.0K | $104.55 | −$1.88M | −65.8%9.36K after | 2 lots10b5-1 |
KYMR Kymera Therapeutics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2024 (view filing) | Jan 23 | Same day | Albers Jeffrey W.Director | SSale | −10.0K | $30.05 | −$300.5K | −100.0%0 after | 10b5-1 |
| Feb 21, 2024 (view filing) | Feb 20-21 | 1 day | Albers Jeffrey W.Director | SSale | −5.00K | $39.05 | −$195.3K | −100.0%0 after | 2 lots10b5-1 |
| Aug 26, 2024 (view filing) | Aug 26 | Same day | Albers Jeffrey W.Director | SSale | −5.00K | $49.10 | −$245.5K | −100.0%0 after | 10b5-1 |
| Jun 3, 2025 (view filing) | Jun 3 | Same day | Albers Jeffrey W.Director | SSale | −6.35K | $49.00 | −$311.1K | −100.0%0 after | 10b5-1 |
| Oct 14, 2025 (view filing) | Oct 13 | 1 day | Albers Jeffrey W.Director | SSale | −5.00K | $59.19 | −$295.9K | −100.0%0 after | 10b5-1 |
| Dec 8, 2025 (view filing) | Dec 8 | Same day | Albers Jeffrey W.Director | SSale | −5.00K | $89.76 | −$448.8K | −100.0%0 after | 2 lots10b5-1 |
BPMC Blueprint Medicines Corp
Director28 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Albers Jeffrey W.CEO and President | SSale | −25.0K | $92.68 | −$2.32M | −12.7%172.4K after | 2 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Albers Jeffrey W.CEO and President | SSale | −5.00K | $115.16 | −$575.8K | −2.6%188.4K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Albers Jeffrey W.CEO and President | SSale | −30.0K | $114.50 | −$3.44M | −13.7%188.4K after | 4 lots |
| Mar 8, 2022 (view filing) | Mar 3-7 | 5 daysLate | Albers Jeffrey W.CEO AND PRESIDENT | SSale | −32.7K | $57.90 | −$1.89M | −15.1%183.2K after | 6 lots |
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Albers Jeffrey W.CEO AND PRESIDENT | SSale | −5.00K | $70.11 | −$350.6K | −2.7%183.2K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Albers Jeffrey W.Director | SSale | −20.0K | $55.89 | −$1.12M | −9.8%183.2K after | 3 lots |
| Aug 10, 2022 (view filing) | Aug 8 | 2 days | Albers Jeffrey W.Director | SSale | −10.0K | $70.07 | −$700.7K | −5.2%183.2K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Albers Jeffrey W.Director | SSale | −20.0K | $68.41 | −$1.37M | −9.8%183.2K after | 3 lots |
| Aug 23, 2022 (view filing) | Aug 19-22 | 4 days | Albers Jeffrey W.Director | SSale | −10.0K | $70.45 | −$704.5K | −5.2%183.2K after | 3 lots |
| Dec 7, 2022 (view filing) | Dec 5 | 2 days | Albers Jeffrey W.Director | SSale | −20.0K | $50.09 | −$1.00M | −9.8%183.2K after |